Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID‐19: A multicentre case series of 98 patients-Reference-Cited by-同舟云学术

Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID‐19: A multicentre case series of 98 patients

Published:2022-01-19 Issue:6 Volume:88 Page:2802-2813
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

van Haren Frank M. P.¹²^ORCID,van Loon Lex M.¹,Steins Anne¹,Smoot Thomas L.³^ORCID,Sas Caitlin³,Staas Sabrina³,Vilaseca Alicia B.⁴,Barbera Ruben A.⁴,Vidmar Gustavo⁴,Beccari Hugo⁴,Popilevsky Frida⁵,Daribayeva Eleonora⁵,Venkatesan Bhuvaneshwari⁵,Mozes Susan⁵,Postel Rachel⁵,Popilevski Natalie⁵,Webb Andrew⁶^ORCID,Nunes Quentin⁷,Laffey John G.⁸⁹^ORCID,Artigas Antonio¹⁰,Smith Roger¹¹,Dixon Barry¹¹,Richardson Alice¹²,Yoon Hwan‐Jin¹²,Page Clive¹³

Affiliation:

1. Australian National University College of Health and Medicine Canberra Australia

2. Intensive Care Unit Saint George Hospital Sydney Australia

3. Frederick Health Hospital Frederick Maryland USA

4. Service of Haematology and Haemostasis San Camilo Clinic Buenos Aires Argentina

5. Surgical Intensive Care Unit Coney Island Hospital Brooklyn New York USA

6. Clinical Pharmacology, School of Cardiovascular Medicine & Sciences King’s College London United Kingdom

7. Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool United Kingdom

8. Anaesthesia and Intensive Care Medicine, School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building National University of Ireland Galway Galway Ireland

9. Department of Anaesthesia, University Hospital Galway Saolta Hospital Group Ireland

10. Critical Center, Corporació Universitaria Sanitaria Parc Tauli, CIBER Enfermedades Respiratorias Autonomous University of Barcelona Sabadell Spain

11. Department of Critical Care Medicine St Vincent’s Hospital Melbourne Australia

12. Statistical Consulting Unit Australian National University Canberra Australia

13. Sackler Institute of Pulmonary Pharmacology King’s College London United Kingdom

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15212

Reference31 articles.

1. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

2. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

3. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

4. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

5. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid;Biomolecules;2024-08-28

2. Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2;Journal of Medicinal Chemistry;2024-07-12

3. The British Journal of Clinical Pharmacology: The first 50 years;British Journal of Clinical Pharmacology;2023-12-28

4. Role of Nebulized Heparin in Clinical Outcome of COVID-19 Patients with Respiratory Symptoms: A Systematic Review;Indian Journal of Critical Care Medicine;2023-07-31

5. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study;Pulmonary Pharmacology & Therapeutics;2023-06